###begin article-title 0
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population
###end article-title 0
###begin p 1
The first three authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 56 66 56 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715,</italic>
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(HTRA1)</italic>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 330 339 330 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
Variants in complement factor H (CFH), the hypothetical LOC387715, and the high-temperature requirement A-1 (HTRA1) genes have been reported to be associated with age-related macular degeneration (AMD). The purpose of this study was to investigate the association of reported common single-nucleotide polymorphisms (SNPs) in CFH, LOC387715, and HTRA1 with exudative AMD in a northern Chinese population.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 206 215 206 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
A cohort of 121 unrelated patients with exudative AMD and 132 control subjects were enrolled in this study. Genomic DNA was extracted from blood leukocytes. Genotyping for SNPs :T>C in CFH (Y402H), :G>T in LOC387715 (A69S), and :G>A in the promoter of HTRA1 was performed using a polymerase chain reaction (PCR) method followed by allele-specific restriction enzyme digestion and direct sequencing.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 239 248 239 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 327 336 327 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 836 845 836 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 869 874 869 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
The Y402H variant in CFH was not associated with exudative AMD in our study population. Frequencies of Y402H was 10.3% in AMD cases and 8.0% in controls (p=0.353). Significant associations were detected for exudative AMD with SNPs :G>T in LOC387715 (A69S), and :G>A in the promoter of HTRA1. The risk T-allele frequency of  in LOC387715 was 64.9% in cases versus 43.2% in controls (p<0.001). The odds ratio for risk of AMD was 1.56 (95% CI; 0.80-3.03) for the GT genotype and 5.45 (95% CI; 2.59-11.49) for the TT genotype. The A allele frequency of  in the HTRA1 promoter was 67.8% in cases versus 42.4% in controls (p<0.001). The odds ratio was 2.75 (95% CI; 1.34-5.64) for the GA genotype and 7.90 (95% CI; 3.61-17.26) for the AA genotype. An odds ratio of 7.94 (95% CI; 3.49-18.04) was obtained for carriers with both TT genotype in LOC387715 and AA genotype in the HTRA1 promoter.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 26 35 26 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
Our data suggest that the LOC387715 and HTRA1 polymorphisms are associated with a higher risk of exudative AMD in northern Chinese. We found no association of CFH Y402H with exudative AMD. The low frequency of CFH Y402H variant was further confirmed in this study population.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 1113 1114 1113 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Age-related macular degeneration (AMD) is a clinically heterogeneous disease and the leading cause of irreversible visual impairment in the elderly population worldwide [1,2]. The early stage of the disease (referred to as age-related maculopathy) is characterized by the presence of drusen with areas of hyperpigmentation or depigmentation. As the disease progresses, two types of late stage AMD develop. The nonexudative AMD (dry or atrophic type) manifests as geographic atrophy or sharply demarcated area of depigmentation caused by atrophy of the retinal pigment epithelium (RPE) and overlying photoreceptors. Exudative AMD (wet or neovascular type) occurs when new blood vessels grow under the RPE or between RPE and neurosensory retina, leading to subretinal hemorrhage and subsequent scar tissue formation. Both nonexudative and exudative AMD result in the loss of central vision; however, nearly 90% of AMD cases with severe vision loss have exudative form of AMD. The Beijing Eye Study revealed that in Chinese older than 40 years, 2% of low vision cases and 7.7% of blindness cases were caused by AMD [3]. As this population ages, these numbers will likely rise.
###end p 12
###begin p 13
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCA4</italic>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FBLN5</italic>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
AMD susceptibility is linked to both genetic and environmental factors, although its precise etiology remains elusive. Reported risk factors include ocular pigmentation, dietary factors, positive family history for AMD, smoking, and several gene mutations such as ATP-binding cassette transporter protein 4 (ABCA4), apolipoprotein E (APOE), and fibulin-5 (FBLN5) [4-9]. Moreover, genome-wide linkage studies have successfully identified several major chromosomal regions including 1q31 and 10q26 [10-14].
###end p 13
###begin p 14
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 434 443 434 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 623 632 623 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 897 906 897 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
Recently, the complement factor H (CFH) gene on chromosome 1q31 has been demonstrated as the first major AMD susceptibility gene, and may associate with 30%-50% of AMD cases [15-18]. The Y402H variant in exon 9 (:T>C) and other intron variants in CFH have been reported to be associated with an increased risk of AMD in more than ten different populations of European descent [15-23]. Susceptibility for AMD at putative genomic locus LOC387715 on chromosome 10q26 was further confirmed in this group [24,25]. The strongest association centered over a frequent coding single-nucleotide polymorphism (SNP), :G>T in exon 1 of LOC387715 (A69S), strongly implicating this gene in the pathogenesis of AMD. Furthermore, studies of Hong Kong Chinese and Caucasian population have identified SNP :G>A in the promoter of high-temperature requirement A-1 (HTRA1) gene, approximately 6.1 kb downstream of  in LOC387715 on chromosome 10q26, to be associated with increased risk of AMD [26,27].
###end p 14
###begin p 15
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 225 234 225 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
It is critical to conduct studies in different populations in order to draw firm conclusions about the role of genetic factors. The purpose of this study was to investigate whether the reported major risk alleles in the CFH, LOC387715, and HTRA1 genes were associated with exudative AMD in our independent cohort of northern Chinese patients.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and control individuals
###end title 17
###begin p 18
###xml 57 65 <span type="species:ncbi:9606">patients</span>
###xml 439 451 <span type="species:ncbi:9606">participants</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
Two independent groups of Chinese individuals, including patients with exudative AMD and control subjects, were recruited during outpatient visits to the Beijing Tongren Hospital, Capital Medical University, China. All cases and controls were unrelated native Chinese from the greater Beijing area, northern China. The study protocol was approved by the Ethics Committee of Beijing Tongren Hospital. Informed consent was obtained from all participants, and the procedures used conformed to the tenets of the Declaration of Helsinki for research involving human subjects. A total of 253 individuals, including 121 cases with exudative AMD (71 males and 50 females) and 132 control subjects (68 males and 64 females) participated in this study. The age range is 50 to 90 years old with mean 66.0 and standard deviation (SD) 8.4 in cases, and 50 to 84 years old with mean 66.1 and SD 6.6 in controls.
###end p 18
###begin title 19
Ophthalmic examination
###end title 19
###begin p 20
###xml 4 16 <span type="species:ncbi:9606">participants</span>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 402 410 <span type="species:ncbi:9606">patients</span>
All participants received a standard ophthalmic examination, including visual acuity measurement, slit-lamp biomicroscopy, and dilated fundus examination that was performed by a retinal specialist. All AMD patients had fluorescein as well as indocyanine green fundus angiography. The diagnosis of exudative AMD was based on ophthalmoscopic and fluorescein angiographic findings. Inclusion criteria for patients were as follows: 1) age of 50 years or older, 2) presence of macular lesions (choroidal neovascular membrane, subretinal hemorrhage, RPE detachment, and fibrovascular disciform scars) in one or both eyes; and 3) macular lesions not associated with other eye diseases, such as degenerative myopia, angioid streaks, or any other retinal/choroidal diseases. Controls were confirmed not to have clinical evidence of early or late AMD in both eyes and not to have any other eye diseases aside from mild age-related cataracts. Subjects with severe cataracts were excluded from the study.
###end p 20
###begin title 21
DNA extraction and polymerase chain reaction
###end title 21
###begin p 22
###xml 562 569 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 724 725 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 786 789 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 846 851 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 38 50 <span type="species:ncbi:9606">participants</span>
###xml 169 180 <span type="species:ncbi:9606">participant</span>
Blood samples were collected from all participants and stored at -80 degreesC before DNA extraction. Genomic DNA was extracted from the peripheral venous blood for each participant using a commercially available genomic DNA extraction and purification kit (TIANamp Swab DNA Kit; Tiangen Biotech, Beijing, China) according to the manufacturer's protocol. Genotyping was performed using a method of polymerase chain reaction (PCR) followed by allele-specific restriction enzyme digestion and direct sequencing. The primer sequences used in this study are given in Table 1. PCR reactions were performed using a DNA thermocycler (Eppendorf, Hamburg, Germany) in a 25 microl mixture containing 2.5 microl 10X buffer (25 mM/L MgCl2 ), 25 microM each of dNTP, 1 pmol of each primer, 0.5 units Taq DNA polymerase, and 50 ng genomic DNA. Amplification of HTRA1 was performed by adding 5% dimethyl sulfoxide (DMSO) to the PCR reaction mixture. Samples were denaturing at 94 degreesC for 5 min followed by 35 cycles under the following conditions: denature at 94 degreesC for 30 s, annealing at 56 degreesC for 30 s, and extension at 72 degreesC for 45 s. The final extension step was lengthened to 5 min. Aliquots of amplified uncut products were resolved by electrophoresis in 2% (w/v) agarose gels with 0.5 microg/ml ethidium bromide and visualized under ultraviolet light. Samples were then used for allele-specific restriction enzyme digestion. Some products were also used for direct sequencing.
###end p 22
###begin title 23
Primers used in polymerase chain reaction amplification and sequencing
###end title 23
###begin p 24
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 166 175 166 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
The primer sequences used in polymerase chain reaction (PCR) amplification and sequencing of the single-nucleotide polymorphisms (SNPs) in complement factor H (CFH), LOC387715, and HTRA1 genes.
###end p 24
###begin title 25
Restriction digestion and direct sequencing
###end title 25
###begin p 26
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 324 327 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 369 378 357 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 392 397 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 831 839 815 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
The amplified products were analyzed by restriction enzyme digestion according to the manufacturer's protocol (New England Biolabs, Ipswich, MA). Enzymes used in this study and the lengths of various restriction fragments are given in Figure 1. Restriction digestion was performed at either 65 degreesC for 3 h (Tsp509I for CFH Y402H) or 37 degreesC for 3 h (PvuII for LOC387715 and EagI for HTRA1). Samples were electrophoresed on a 2% (w/v) agarose gel with 0.5 microg/ml ethidium bromide. Images of the gel were taken with a Molecular Imager Gel Doc XR System (Bio-Rad, Hercules, CA). Genotypes were determined based on the restriction patterns and were further confirmed by direct sequencing of the PCR products using an automatic ABI 3730XL DNA Analyzer (Applied Biosystems, Foster City, CA) in a selected subset of subjects (Figure 1).
###end p 26
###begin p 27
###xml 162 164 162 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 327 329 327 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 418 420 418 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 446 455 446 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 548 550 548 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</bold>
###xml 601 610 601 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 612 614 612 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E:</bold>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 738 740 738 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F:</bold>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
Ethidium bromide-stained 2% agarose gels and direct sequencing, showing the PCR-restriction fragment length polymorphism and corresponding sequence chromatogram. A: Restriction analysis for complement factor H (CFH) Y402H polymorphism resulted in digestible fragment (T/T), undigestible fragment (C/C), and heterozygote (T/C). B: Direct sequencing of the PCR products confirmed the restriction patterns for CFH Y402H. C: Restriction analysis for LOC387715 resulted in digestible fragment (G/G), undigestible fragment (T/T), and heterozygote (T/G). D: Sequencing confirmed the restriction patterns for LOC387715. E: Restriction analysis for HTRA1 resulted in digestible fragment (G/G), undigestible fragment (A/A), and heterozygote (G/A). F: Sequencing confirmed the restriction patterns for HTRA1.
###end p 27
###begin title 28
Statistical analysis
###end title 28
###begin p 29
###xml 36 37 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 230 232 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 275 276 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 370 371 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 477 479 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
Hardy Weinberg equilibrium (HWE) chi2 values in cases and controls were calculated to identify possible genotyping errors. Linkage disequilibrium (LD) was measured by the D' value using statistical software Haploview version 4.0 [28]. Numerical data were examined by Student t test. Genotypes and allele frequencies between cases and controls were compared using the chi2 test. Odd ratios (OR) and 95% confidence intervals (CI) were calculated according to the Woolf equation [29]. A p-value of <0.05 was considered statistically significant.
###end p 29
###begin title 30
Results
###end title 30
###begin p 31
###xml 117 124 117 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 233 234 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 332 333 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
Case-control samples were composed of 121 unrelated patients with exudative AMD and 132 healthy control individuals (Table 2). The mean ages were 66.0+/-8.4 for AMD patients and 66.1+/-6.6 years for healthy controls (p=0.94, Student t test). Percentage of males was 58.7% in the AMD group and 51.5% in the control group (p=0.25, chi2 test).
###end p 31
###begin title 32
###xml 15 23 <span type="species:ncbi:9606">patients</span>
Age and sex of patients with exudative AMD and control subjects
###end title 32
###begin p 33
###xml 283 284 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
The case-control samples were composed of 121 unrelated patients with exudative age-related macular degeneration (AMD) and 132 control individuals. No statistical difference was observed between AMD patients and controls groups for age (p=0.94, Student t test) or gender (p=0.25, chi2 test).
###end p 33
###begin p 34
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 129 138 129 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 494 497 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 499 508 499 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 78 90 <span type="species:ncbi:9606">participants</span>
###xml 297 309 <span type="species:ncbi:9606">participants</span>
Genotypes were determined successfully by restriction enzyme digestion in all participants for SNPs :T>C in CFH (Y402H), :G>T in LOC387715 (A69S), and :G>A in the promoter region of HTRA1 (Table 3). Genotypes were confirmed by direct sequencing in 82 randomly selected subjects, including 40 case participants and 42 control individuals, and the sequencing data were consistent with the restriction enzyme digestion results in all studied subjects. Genotype distributions for SNPs at gene loci CFH, LOC387715, and HTRA1 were in Hardy-Weinberg equilibrium in either AMD cases or control subjects (p-value >/= 0.283).
###end p 34
###begin title 35
Genotype and allele frequencies in cases with exudative AMD and controls
###end title 35
###begin p 36
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 135 144 135 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
This table summarizes the genotype and allele frequencies for the single-nucleotide polymorphisms (SNPs) in complement factor H (CFH), LOC387715, and HTRA1 genes among patients with exudative age-related macular degeneration (AMD) and control subjects. Genotype distributions for SNPs were in Hardy-Weinberg (H-W) equilibrium in either cases or controls. The p-value represents comparison or level of risk significance between AMD cases and controls. Adjustment for multiple comparisons was made using Bonferroni method, which did not change the significant levels for all three SNPs. OR indicates odds ratio and CI refers to confidence interval.
###end p 36
###begin p 37
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 101 108 101 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 216 217 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 358 359 354 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 13 25 <span type="species:ncbi:9606">participants</span>
Between case participants and controls, the CFH variant Y402H was not associated with exudative AMD (Table 3). The frequencies for the risk C allele at Y402H were 10.3% in AMD cases and 8.0% in controls (p=0.353, chi2 test) in the study population. No significant difference between the CFH genotypes in AMD group and control group was observed (p=0.496, chi2 test). Compared to the wild-type homozygous TT genotype, the OR for heterozygous TC genotype was 1.25 (95% CI; 0.65-2.40). The OR for homozygous CC genotype was not calculated since the CC homozygote was identified only in one case in this Chinese cohort.
###end p 37
###begin p 38
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 80 87 80 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 181 182 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 300 301 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
A strong association with exudative AMD was detected for SNP :G>T in LOC387715 (Table 3). The risk T allele frequencies were 64.9% for AMD cases and 43.2% for controls (p<0.001, chi2 test). Genotype distributions between AMD cases and controls were statistically significantly different (p<0.001, chi2 test). Compared to wild-type GG genotype, the OR for the risk of AMD was 1.56 (95% CI; 0.80-3.03) for the heterozygous GT genotype and 5.45 (95% CI; 2.59-11.49) for the homozygous TT genotype.
###end p 38
###begin p 39
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 98 105 98 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 202 203 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 344 345 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Similarly, the SNP :G>A in the promoter of HTRA1 was significantly associated with exudative AMD (Table 3). Frequencies of the risk A allele were 67.8% for AMD cases and 42.4% for controls (p<0.001, chi2 test). Genotypes of this HTRA1 promoter polymorphism between AMD cases and controls were statistically significantly different (p<0.001, chi2 test). The OR was 2.75 (95% CI; 1.34-5.64) for the heterozygous GA genotype and 7.90 (95% CI; 3.61-17.26) for the homozygous AA genotype, compared to the wild-type GG genotype.
###end p 39
###begin p 40
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 221 230 221 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 250 255 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 257 264 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 267 276 267 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
The LOC387715 and HTRA1 genotype combination frequencies in patients with exudative AMD and control subjects are shown in Table 4. An OR of 7.94 (95% CI; 3.49-18.04) was obtained for carriers with combined TT genotype of LOC387715 and AA genotype of HTRA1 (Table 4). LOC387715 and HTRA1 were in high LD in cases (D'=0.98, LOD=38.09, r2=0.843) and in controls (D'=0.869, LOD=32.55, r2=0.732).
###end p 40
###begin title 41
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
LOC387715 and HTRA1 genotype combination frequencies in patients with exudative AMD and control subjects
###end title 41
###begin p 42
###xml 32 41 32 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 208 217 208 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
This table shows the two-locus (LOC387715 and HTRA1) genotype combination frequencies in patients with exudative age-related macular degeneration (AMD) and control subjects. The combined presence of the risk LOC387715 TT genotype and HTRA1 AA genotype was more commonly found in cases than in controls and represented an increased risk for AMD. OR indicates odds ratio and CI refers to confidence interval.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1478 1480 1478 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 1481 1483 1481 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1630 1632 1630 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1633 1635 1633 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 1734 1736 1734 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
The missense polymorphism Y402H in CFH () has been identified as a common nonsynonymous variant and a major genetic risk factor for AMD development in Caucasian populations. Frequencies of the risk C allele in Caucasians were between 61%-94% in AMD and 34%-46% in controls [15-21]. In contrast, in our northern Chinese study population, the C allele was low in frequency (10.3% in cases and 8.0% in controls) and was not associated with exudative AMD. Other research groups in Hong Kong and Taiwan also reported low frequencies of the risk C allele in their study populations [30,31]. In Hong Kong Chinese, the frequency of the risk C allele was 5.8% in AMD cases and 3.9% in controls [30]. In Taiwan Chinese, the frequency of the risk C allele was 11.3% in AMD cases and 2.8% in controls [31]. Their conclusions about the association of Y402H with exudative AMD, however, were controversial. Chen et al. [30] found no association between the Y402H polymorphism and exudative AMD in Hong Kong Chinese population as we did in our study. Lau et al. [31] concluded, however, that Y402H was significantly associated with exudative AMD in Taiwan Chinese. This disparity may be due to sampling bias, difference in inclusion criteria, demographic factors, or variations in Chinese subpopulations. Nonetheless, the genetic attributable risk of Y402H in Chinese populations could not be substantial because the allele frequency was low based on the current study and the data of others [30,31]. Several case-control studies in Japanese populations have shown that the Y402H variant was also at a low frequency and not associated with AMD [32-35]. Dramatic differences may exist in the allele frequencies of individual SNPs across populations [36].
###end p 44
###begin p 45
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 371 374 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 498 501 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 1100 1102 1100 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 1103 1105 1103 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 1359 1362 1359 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 1421 1423 1421 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1424 1426 1424 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 1427 1429 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r42">42</xref>
###xml 1430 1432 1430 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 1595 1597 1595 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 1598 1600 1598 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r46">46</xref>
CFH is involved in the regulation of the alternative complement pathway. Complement components have previously been found in drusen, an inflammatory deposit between retinal pigment epithelium and neuron-sensory retina, suggesting dysregulation of complement activation may be involved in AMD development [37]. Recently, Laine et al. [38] reported that the binding of the CFH Y402H variant to C-reactive protein was strongly reduced compared to the wild-type, indicating that the association of the CFH Y402H with AMD could be due to reduced clearance of cellular debris and increased local inflammation. Magnusson et al. [39] demonstrated that the Y402H variant confers a similar risk of soft drusen and advanced forms of AMD, and hypothesized that the Y402H variant is a major risk factor for soft drusen formation but additional genetic as well as environmental factors may affect progression to exudative AMD. In studies conducted in the Chinese population, however, drusen is less frequently observed and the prevalence of late-stage AMD has been found to be lower when compared with Caucasians [40,41]. The low frequency of Y402H variant and its genetic susceptibility to AMD in our cohort as presented in this study may correlate with the epidemiological features of AMD in the Chinese population. Similar phenotypes of AMD and genetic correlation with CFH Y402H variant have been reported in Japanese populations [32-35,42,43]. A relationship between ethnic differences in disease-susceptible genetic variants and ethnic diversity in phenotypes has also been suggested in other diseases [44-46].
###end p 45
###begin p 46
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r47">47</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r49">49</xref>
###xml 314 323 314 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r50">50</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r52">52</xref>
###xml 524 533 524 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 642 651 642 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 846 855 846 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 998 1003 998 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 1160 1169 1160 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1193 1198 1193 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
In contrast to CFH Y402H variant, our data demonstrate strong associations for the risk of exudative AMD with LOC387715 and HTRA1 variants. Consistent with previous published findings for the Hong Kong Chinese [26] and Caucasian populations [27,47-49], our study shows that AMD risk is higher with the T allele of LOC387715 or the A allele of  in the promoter region of HTRA1. This finding is also consistent with those of Japanese studies published recently [50-52]. The data presented here support the hypothesis that the LOC387715 and HTRA1 genes associate with susceptibility to AMD development across diverse ethnicities. In this study, LOC387715 and HTRA1 showed similar significance levels. ORs for exudative AMD were 1.56 (95%CI, 0.80-3.03) for the heterozygous GT genotype and 5.45 (95%CI, 2.59-11.49) for the homozygous TT genotypes of LOC387715, when compared to the wild GG genotype. ORs for exudative AMD with heterozygous GA genotype and homozygous AA genotype of  in the promoter of HTRA1 were 2.75 (95% CI; 1.34-5.64) and 7.90 (95% CI; 3.61-17.26), respectively, when compared to the wild-type GG genotype. Individuals with both TT genotype of LOC387715 and the AA genotype of HTRA1 associated with an OR of 7.94 (95% CI; 3.49-18.04), similar to the risk conferred by  or  alone. Based on the likelihood ratio test, no interaction or combined effect was evident between the two SNPs:  and .
###end p 46
###begin p 47
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</italic>
###xml 149 158 149 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 369 378 369 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 450 455 450 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 630 639 630 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 680 689 680 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 882 887 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 1015 1017 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 1031 1040 1031 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1050 1055 1050 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 1204 1209 1204 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 1263 1268 1263 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 1400 1409 1400 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1587 1589 1587 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 1614 1616 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r53">53</xref>
###xml 1887 1896 1887 1896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1901 1906 1901 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 1969 1978 1969 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 1983 1988 1983 1988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 281 286 <span type="species:ncbi:9606">human</span>
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 1434 1439 <span type="species:ncbi:9606">human</span>
LOC387715 and HTRA1 are both located on the chromosome 10q26 region, which is one of the major chromosomal regions identified for AMD susceptibility.LOC387715 encodes a hypothetical protein of unknown function and is highly expressed in placental tissue, but its expression in the human retina is weak [24]. The risk T allele of SNP  maps to exon 1 of the hypothetical LOC387715 gene and changes putative amino acid 69 from alanine to serine (A69S). HTRA1 encodes a heat shock serine protease and is expressed in the mouse and human retina [26]. SNP  resides in the promoter of HTRA1 and is approximately 6.1 kb downstream of the LOC387715. Because only a single cDNA sequence of LOC387715 has been found, DeWan and co-authors [26] hypothesized that SNP  is a surrogate marker that is correlated, or is in LD, with the putative AMD disease-causing variant. They thus concluded that HTRA1 is a major risk factor for exudative AMD. Contrary to the reports of DeWan et al. and others [26,27], a study by Kanda et al. [53] showed that LOC387715, but not HTRA1, represents a major susceptibility variant for AMD at 10q26. In their study, Kanda and coauthors [53] showed that SNP  has no significant impact on HTRA1 promoter activity in three different cell lines, and HTRA1 mRNA expression exhibits no significantly different change between control and AMD retinas. However, it has been demonstrated that LOC387715 mRNA is detected in the human retina and various cell lines and encodes a 12 kDa protein, which localizes to the mitochondrial outer membrane when expressed in mammalian cells [53]. Kanda and co-authors [53] therefore proposed that the A69S change in the LOC387715 protein affects its presumptive function in mitochondria and enhances the susceptibility to aging-associated degeneration of macular photoreceptors. In agreement with previous studies, we show in this study that LOC387715 and HTRA1 are in high LD. Further studies are needed to clarify whether LOC387715 and HTRA1 are only in LD or are causative factors for AMD.
###end p 47
###begin p 48
###xml 39 48 39 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387715</italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HTRA1</italic>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFH</italic>
In summary, our data demonstrated that LOC387715 and HTRA1, but not the CFH Y402H polymorphism, conferred significantly increased risk for exudative AMD in a northern Chinese population. Replication of association studies in diverse ethnic groups worldwide may provide a better appreciation of the genetic contributions in AMD pathogenesis. Further studies would be needed to determine the identity of causal variant and to evaluate the possible mechanisms through which the variant influences the disease susceptibility.
###end p 48
###begin title 49
Acknowledgments
###end title 49
###begin p 50
###xml 71 83 <span type="species:ncbi:9606">participants</span>
The authors would like to express our greatest appreciation to all the participants in the study. This work was supported by the National Basic Research Program of China (973 Program) Grant 2007CB512200 and the Beijing Medical Development Foundation Grant 2002-1019.
###end p 50
###begin title 51
References
###end title 51
###begin article-title 52
Prevalence of age-related macular degeneration in the United States.
###end article-title 52
###begin article-title 53
The Bowman lecture. Towards an understanding of age-related macular disease.
###end article-title 53
###begin article-title 54
Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.
###end article-title 54
###begin article-title 55
Genetic association of apolipoprotein E with age-related macular degeneration.
###end article-title 55
###begin article-title 56
Missense variations in the fibulin 5 gene and age-related macular degeneration.
###end article-title 56
###begin article-title 57
Risk factors for age-related macular degeneration: Pooled findings from three continents.
###end article-title 57
###begin article-title 58
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.
###end article-title 58
###begin article-title 59
Cigarette smoking and age-related macular degeneration in the EUREYE Study.
###end article-title 59
###begin article-title 60
Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q.
###end article-title 60
###begin article-title 61
Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26.
###end article-title 61
###begin article-title 62
Meta-analysis of genome scans of age-related macular degeneration.
###end article-title 62
###begin article-title 63
Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.
###end article-title 63
###begin article-title 64
Susceptibility genes for age-related maculopathy on chromosome 10q26.
###end article-title 64
###begin article-title 65
Complement factor H polymorphism and age-related macular degeneration.
###end article-title 65
###begin article-title 66
Complement factor H polymorphism in age-related macular degeneration.
###end article-title 66
###begin article-title 67
Complement factor H variant increases the risk of age-related macular degeneration.
###end article-title 67
###begin article-title 68
Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.
###end article-title 68
###begin article-title 69
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.
###end article-title 69
###begin article-title 70
Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers.
###end article-title 70
###begin article-title 71
Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population.
###end article-title 71
###begin article-title 72
CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration.
###end article-title 72
###begin article-title 73
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.
###end article-title 73
###begin article-title 74
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.
###end article-title 74
###begin article-title 75
Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.
###end article-title 75
###begin article-title 76
HTRA1 promoter polymorphism in wet age-related macular degeneration.
###end article-title 76
###begin article-title 77
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.
###end article-title 77
###begin article-title 78
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 78
###begin article-title 79
On estimating the relation between blood group and disease.
###end article-title 79
###begin article-title 80
Association of complement factor H polymorphisms with exudative age-related macular degeneration.
###end article-title 80
###begin article-title 81
###xml 126 134 <span type="species:ncbi:9606">patients</span>
Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients.
###end article-title 81
###begin article-title 82
No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese.
###end article-title 82
###begin article-title 83
Polymorphisms in Complement Factor H and Hemicentin-1 genes in a Japanese population with dry-type age-related macular degeneration.
###end article-title 83
###begin article-title 84
Complement factor H polymorphisms in Japanese population with age-related macular degeneration.
###end article-title 84
###begin article-title 85
No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population.
###end article-title 85
###begin article-title 86
Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His.
###end article-title 86
###begin article-title 87
The role of inflammation in the pathogenesis of age-related macular degeneration.
###end article-title 87
###begin article-title 88
Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.
###end article-title 88
###begin article-title 89
CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.
###end article-title 89
###begin article-title 90
Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study.
###end article-title 90
###begin article-title 91
Associated factors for age related maculopathy in the adult population in China: the Beijing eye study.
###end article-title 91
###begin article-title 92
Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study.
###end article-title 92
###begin article-title 93
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of exudative age-related macular degeneration in Japanese patients.
###end article-title 93
###begin article-title 94
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.
###end article-title 94
###begin article-title 95
Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association.
###end article-title 95
###begin article-title 96
Ethnic differences in allele frequency of autoimmune-disease-associated SNPs.
###end article-title 96
###begin article-title 97
The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples.
###end article-title 97
###begin article-title 98
Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population.
###end article-title 98
###begin article-title 99
Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population.
###end article-title 99
###begin article-title 100
A polymorphism of LOC387715 gene is associated with age-related macular degeneration in the Japanese population.
###end article-title 100
###begin article-title 101
HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration.
###end article-title 101
###begin article-title 102
A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration.
###end article-title 102

